Procept (PRCT): 50% rise on high volume. Why? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?

PRCT 30.64

-0.4%

10:56 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Douglas who wrote (72)	4/4/1997 8:15:00 PM
From: Gerald Thomas	of 455

If the active ingredient "pro-2000" is effective in treating or preventing infection of hiv 10 - 15$ may be conservative. I owned Agouron pharmaceuticals in the early stages when they were in trials and that stock has been in the 100$ range recently.. But that still brings me back to problems with the company reporting results and keeping timetables. Phase I results of this trial will tell you almost nothing...whether the compound caused reactions to skin...three months to hear that... then there is a cash problem..not to mention the systemic trial which under the continuous infusion protocol had to be halted and reconfigured and the the new systemic trial started last may and went close to a year and now another change of direction with maybe no explanation...what does all this tell you? I'm not saying the company doesn't have anything...just that they ought to look at the stock price and see if there is a better approach to explaining things......

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next